CARL logo

CARL
Carlsmed Inc

54
Mkt Cap
$238.98M
Volume
112,752.00
52W High
$17.19
52W Low
$8.87
PE Ratio
-7.80
CARL Fundamentals
Price
$8.94
Prev Close
$9.72
Open
$9.60
50D MA
$11.41
Beta
1.40
Avg. Volume
128,091.96
EPS (Annual)
-$1.14
P/B
2.41
Rev/Employee
$397,724.41
$236.09
Loading...
Loading...
News
all
press releases
Carlsmed (NASDAQ:CARL) Price Target Lowered to $17.00 at The Goldman Sachs Group
The Goldman Sachs Group decreased their price objective on Carlsmed from $19.00 to $17.00 and set a "buy" rating for the company in a report on Thursday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Carlsmed (NASDAQ:CARL) Upgraded by Zacks Research to Hold Rating
Zacks Research upgraded shares of Carlsmed from a "strong sell" rating to a "hold" rating in a research report on Thursday...
MarketBeat·14d ago
News Placeholder
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Hold" from Analysts
Carlsmed, Inc. (NASDAQ:CARL - Get Free Report) has been given an average rating of "Hold" by the five ratings firms that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating and three have assigned a buy rating to the company. Th...
MarketBeat·18d ago
News Placeholder
Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference
Carlsmed (NASDAQ:CARL) used its presentation at Canaccord Genuity's Musculoskeletal Conference to outline its mission to improve outcomes and reduce the cost of spine surgery by lowering reoperation...
MarketBeat·1mo ago
News Placeholder
Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages
Carlsmed, Inc. (NASDAQ:CARL - Get Free Report) has been given a consensus recommendation of "Hold" by the five ratings firms that are currently covering the firm, MarketBeat.com reports. Two analysts...
MarketBeat·1mo ago
News Placeholder
Carlsmed (NASDAQ:CARL) Lowered to Strong Sell Rating by Zacks Research
Zacks Research lowered shares of Carlsmed from a "hold" rating to a "strong sell" rating in a report on Wednesday...
MarketBeat·1mo ago
News Placeholder
Carlsmed Q4 Earnings Call Highlights
Carlsmed (NASDAQ:CARL) reported rapid growth in the fourth quarter and full year 2025, highlighting record revenue, gross margin expansion, and increasing surgeon adoption as the company scaled its...
MarketBeat·1mo ago
News Placeholder
Carlsmed (NASDAQ:CARL) Issues Quarterly Earnings Results
Carlsmed (NASDAQ:CARL - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.32) earnings per share (EPS) for the quarter, beating the consensus estimate of...
MarketBeat·1mo ago
News Placeholder
Carlsmed Unveils Custom Cervical Plating Tech
Carlsmed (NASDAQ: CARL) stock rises on news of first personalized cervical plating procedure with its corra system.read more...
Benzinga·2mo ago
News Placeholder
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to "Hold"
Wall Street Zen upgraded shares of Carlsmed from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·2mo ago
<
1
2
...
>

Latest CARL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.